Psychedelics Stock MindMed Stumbles On 2020 Results

A psychedelic medicine biotech company, Mind Medicine Inc. MMED MMEDF MMQ, released full-year 2020 financial results Tuesday. 

MindMed posted a net and comprehensive loss of $35.1 million for the year ended Dec. 31, 2020.

Its total assets at the end of the reporting period were $85.6 million, counting $80.1 million in cash.

The company used $24.2 million of net cash in operating activities in 2020.

Its cash balance as of Tuesday hovers at $161 million, which the company said it plans to use to improve its portfolio and develop its technology sector.

MindMed will hold an earnings call Thursday, April 1.

MindMed's Recent Activities

In February, the company entered into the "Psychedelic 2.0" space via a collaboration with MindShift Compounds AG, a Swiss startup working in the development of second-generation psychedelic molecules.

It also acquired the artificial intelligence medicine companyHealthMode in a $32.5-million stock-and cash-deal. Health Mode is a digital medicine and therapeutics startup that uses artificial intelligence-equipped digital measurement to improve the precision and speed of clinical research and patient monitoring.

In March, MindMed closed a CA$19.5 million ($15.4 million) bought deal private placement offering, increasing its cash on hand to CA $162 million. 

At the time of writing, MindMed shares were trading 4.87% lower at $2.27 per share. 

Market News and Data brought to you by Benzinga APIs
Posted In: CannabisEarningsNewsMarketscannabis industrycannabis salesHealth Modelegal marijuanamarijuanamarijuana stocksMind Medicine IncMind Medicine Inc earningsMind Medicine Inc sharesMindMed Bought Deal offeringMindMed Financial ResultsMindShift Compounds AGPsychedelicPsychedelic 2.0Psychedelics
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

The Benzinga Cannabis Capital Conference is coming to Florida

The Benzinga Cannabis Capital Conference is returning to Florida, in a new venue in Hollywood, on April 16 and 17, 2024. The two-day event at The Diplomat Beach Resort will be a chance for entrepreneurs, both large and small, to network, learn and grow. Renowned for its trendsetting abilities and influence on the future of cannabis, mark your calendars – this conference is the go-to event of the year for the cannabis world.

Get your tickets now on – Prices will increase very soon!